Carnation Inds. (530609)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹7.31 |
| Market Cap | ₹2.65 Cr |
| P/E Ratio | 0 |
| ROCE | 200% |
| ROE | -116.28% |
| Dividend Yield | 0% |
| Profit Growth | -100% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹21.07 — ₹88.65 |
| Sector | Industrial Products |
| Book Value | ₹3.44 |
Strengths
- Book value is positive at ₹3.44 per share, so there is some tangible asset backing, albeit at a premium price.
- Market cap is only ₹3 Cr, limiting the absolute Rupee downside for a speculative position.
- Reported ROCE of 200% suggests the capital base is small and could become highly profitable if real revenue returns.
- Piotroski F-Score of 3/9 is weak but not zero, leaving some room for a financial recovery.
Concerns
- Latest quarter has zero sales and a ₹1 Cr net loss—there is no revenue engine.
- ROE of -116.28% means shareholder equity is being eroded fast.
- At P/B of 2.13, the market price is more than double book value for a loss-making company.
- Current price of ₹7.31 is below the stated 52-week low of ₹21.07, signalling data issues or severe distress.
- No promoter holding disclosure, no dividend, and insufficient data for a FairStock score.
AI Analysis
Let me put it plainly: Carnation Inds. is not a business I can value. The latest quarter shows sales of ₹0 Cr and a net loss of ₹1 Cr. A company with no revenue cannot compound wealth; it is consuming capital. Graham taught me to buy with a margin of safety, but at ₹7.31 I am paying 2.13 times a book value of ₹3.44. The P/E is meaningless because there is no earnings figure to trust; profit growth is down 100%. The ROE of -116.28% tells me equity is being destroyed rapidly. A Piotroski F-Score of 3 out of 9 supports the picture of weak financial health. I also see a strange 52-week range: ₹21.07–₹88.65, yet the price is ₹7.31. That alone makes me question the reliability of the market data or the severity of the distress. On top of that, promoter holding is not disclosed, there is no dividend, and the FairStock Score is unavailable due to insufficient data. A reported ROCE of 200% might look tempting, but with zero sales I cannot treat it as evidence of an operating moat; it is more likely a reflection of a tiny capital base. Some might call this a possible turnaround, but a turnaround requires a plan and visible traction: new orders, revenue, positive cash flow. I have none of that here. A low-priced stock is not a bargain. A loss-making shell with negative returns and no revenue is exactly the kind of situation I avoid. I would pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer